Empowered Funds LLC cut its holdings in Proto Labs, Inc. (NYSE:PRLB – Free Report) by 74.8% during the third quarter, according to its most recent Form 13F filing with the SEC. The fund owned 14,801 shares of the industrial products company’s stock after selling 43,856 shares during the period. Empowered Funds LLC owned 0.06% of Proto Labs worth $435,000 at the end of the most recent reporting period.
A number of other hedge funds have also modified their holdings of PRLB. Canada Pension Plan Investment Board acquired a new position in Proto Labs in the second quarter valued at about $37,000. Innealta Capital LLC purchased a new position in shares of Proto Labs during the 2nd quarter worth approximately $40,000. KBC Group NV increased its holdings in Proto Labs by 69.3% in the 3rd quarter. KBC Group NV now owns 1,541 shares of the industrial products company’s stock valued at $45,000 after purchasing an additional 631 shares during the last quarter. Meeder Asset Management Inc. purchased a new stake in Proto Labs in the second quarter valued at approximately $80,000. Finally, Shell Asset Management Co. acquired a new position in Proto Labs during the first quarter worth $132,000. 84.54% of the stock is currently owned by hedge funds and other institutional investors.
Proto Labs Stock Performance
PRLB stock opened at $41.50 on Monday. The company’s 50 day moving average price is $31.60 and its 200 day moving average price is $31.17. The firm has a market capitalization of $1.02 billion, a price-to-earnings ratio of 44.15 and a beta of 1.32. Proto Labs, Inc. has a fifty-two week low of $25.75 and a fifty-two week high of $41.87.
Analyst Upgrades and Downgrades
PRLB has been the subject of a number of research analyst reports. Needham & Company LLC restated a “hold” rating on shares of Proto Labs in a report on Friday, November 1st. StockNews.com cut shares of Proto Labs from a “strong-buy” rating to a “buy” rating in a report on Monday, August 5th. Cantor Fitzgerald reiterated an “overweight” rating and set a $40.00 target price on shares of Proto Labs in a report on Monday, November 4th. Finally, Craig Hallum raised their price target on shares of Proto Labs from $30.00 to $36.00 and gave the company a “hold” rating in a research report on Monday, November 4th. Two investment analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $40.33.
Read Our Latest Analysis on PRLB
Insiders Place Their Bets
In related news, CEO Robert Bodor purchased 3,480 shares of the company’s stock in a transaction on Friday, September 6th. The shares were bought at an average cost of $28.68 per share, for a total transaction of $99,806.40. Following the completion of the purchase, the chief executive officer now directly owns 80,878 shares of the company’s stock, valued at approximately $2,319,581.04. This trade represents a 4.50 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this link. 1.20% of the stock is owned by company insiders.
About Proto Labs
Proto Labs, Inc, together with its subsidiaries, operates as a digital manufacturer of custom parts in the United States and Europe. The company offers injection molding; computer numerical control machining; three-dimensional printing; and sheet metal fabrication products. It serves developers and engineers, who use 3D computer-aided design software to design products across a range of end-markets.
Featured Articles
- Five stocks we like better than Proto Labs
- Comparing and Trading High PE Ratio Stocks
- Disney’s Magic Strategy: Reinventing the House of Mouse
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Volatility in Semis? 3 Stable Alternatives to NVIDIA and SMCI
- Basic Materials Stocks Investing
- Vertiv’s Cool Tech Makes Its Stock Red-Hot
Want to see what other hedge funds are holding PRLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Proto Labs, Inc. (NYSE:PRLB – Free Report).
Receive News & Ratings for Proto Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proto Labs and related companies with MarketBeat.com's FREE daily email newsletter.